Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it

Page 10 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.

• Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?CompletedNCT05895643Phase 2
• Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)CompletedNCT05892432Phase 2
• Semaglutide Therapy for Alcohol Reduction - TulsaCompletedNCT05891587Phase 2
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)CompletedNCT05890976Phase 3
• Novel Therapeutics and Endothelial Dysfunction in T1DM PatientsCompletedNCT05857085Phase 4
• Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaWithdrawnNCT05829460Phase 2
• A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes MellitusCompletedNCT05816057Phase 3
• Semaglutide in Nonalcoholic Fatty Liver DiseaseCompletedNCT05813249Phase 4
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskCompletedNCT05803421Phase 3
• A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy ParticipantsCompletedNCT05784402Phase 1
• Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 AnalogueStatus unknownNCT05767255Phase 3
• A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedNCT05766709Phase 1
• A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906CompletedNCT05751226Phase 1
• A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive, not recruitingNCT05726227Phase 3
• A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) DoseCompletedNCT05689099Phase 1
• Assessment of Safety, Tolerability and Drug Levels of Exenatide ImplantCompletedNCT05670379Phase 1
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsActive, not recruitingNCT05669755Phase 3
• FTIH of ECC5004 in Healthy and Diabetic ParticipantsCompletedNCT05654831Phase 1
• Comparison of Body Weight Change Through Different Smeglutide Administration MethodsStatus unknownNCT05616052Phase 4
• Exenatide for Smoking Cessation and Prevention of Weight GainCompletedNCT05610800Phase 2
• A Study of IBI362 in Participants With Type 2 DiabetesCompletedNCT05606913Phase 3
• Glucagon-like Peptide-1 Agonism With Very Low Calorie DietsStatus unknownNCT05606471Phase 4
• Young Adults With Early-onset Obesity Treated With SemaglutideCompletedNCT05574439Phase 4
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightActive, not recruitingNCT05567796Phase 3
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityActive, not recruitingNCT05556512Phase 3
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesCompletedNCT05536804Phase 2
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese MenCompletedNCT05498610Phase 1
• Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes MellitusCompletedNCT05467514Phase 3
• Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and ObesityWithdrawnNCT05444153Phase 3
• Efficacy of Oral Semaglutide in Overweight or ObesityStatus unknownNCT05442450Phase 4
• A Study of Cardiovascular Events iN Diabetes PlusActive, not recruitingNCT05441267Phase 4
• A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCompletedNCT05435677Phase 1
• A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesActive, not recruitingNCT05433584Phase 4
• A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One TabletCompletedNCT05429593Phase 1
• A Study in Healthy Men to Test How BI 456906 is Processed in the BodyCompletedNCT05421338Phase 1
• A Study of LY3532226 in Participants With Type 2 Diabetes MellitusCompletedNCT05407961Phase 1
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCompletedNCT05394519Phase 3
• Obesity Treatment to Improve DiabetesCompletedNCT05390307Not applicable
• A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT05377333Phase 1
• Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection FractionCompletedNCT05371496Phase 4
• Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic InpatientsCompletedNCT05360537Phase 4
• Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes MellitusCompletedNCT05360147Phase 3
• Semaglutide in Comorbid Schizophrenia Spectrum Disorder and ObesityActive, not recruitingNCT05333003Not applicable
• LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesCompletedNCT05313529Not applicable
• Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 DiabetesCompletedNCT05303857Phase 4
• A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906CompletedNCT05296733Phase 1
• Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.Status unknownNCT05285397Not applicable
• Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight LossStatus unknownNCT05268627Not applicable
• Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)Active, not recruitingNCT05254314Phase 2
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."Status unknownNCT05249881Early Phase 1
• A Clinical Trial Looking at the Comparability of 2 Different Forms of SemaglutideCompletedNCT05232708Phase 1
• A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese SubjectsCompletedNCT05225974Phase 1
• Basal Plus GLP1-ra on Glycemic Variability in CKDCompletedNCT05218915Phase 4
• Semaglutide to Reduce Atrial Fibrillation BurdenSuspendedNCT05209165Phase 4
• A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the LiverActive, not recruitingNCT05202353Phase 1
• Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related PrediabetesCompletedNCT05193578Phase 2
• A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After MenopauseCompletedNCT05153564Phase 1
• Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes PatientsStatus unknownNCT05147896Not applicable
• Latino Semaglutide StudyCompletedNCT05087342Phase 3
• The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 DiabetesCompletedNCT05078255Not applicable
• Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver DiseaseActive, not recruitingNCT05067621Phase 2
• Human Bioequivalence Test of Liraglutide InjectionCompletedNCT05029076Phase 1
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)CompletedNCT05016882Phase 2
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedNCT05013229Phase 3
• The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.Status unknownNCT05005741Phase 4
• Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)CompletedNCT04979130Phase 4
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityCompletedNCT04940078Phase 1
• Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle CareTerminatedNCT04938388Phase 4
• Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesCompletedNCT04916470Phase 3
• A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With LiraglutideCompletedNCT04903509Phase 1
• Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)CompletedNCT04897802Phase 4
• Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 DiabetesStatus unknownNCT04893148Phase 4
• Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?Active, not recruitingNCT04892199Phase 4
• SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without DiabetesCompletedNCT04889183Phase 3
• Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF PatientsWithdrawnNCT04885634Phase 3
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese MenCompletedNCT04878406Phase 1
• GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)CompletedNCT04876027Phase 4
• The Effect of Semaglutide on Pituitary FunctionCompletedNCT04865744Phase 4
• The Effect and the Pharmacogenomics Study of Liraglutide in Obese PatientsWithdrawnNCT04839237Phase 2
• Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using MetforminCompletedNCT04829903Not applicable
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)Active, not recruitingNCT04822181Phase 3
• A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide TabletsCompletedNCT04817644Phase 1
• Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?CompletedNCT04781998Phase 4
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)CompletedNCT04777409Phase 3
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)CompletedNCT04777396Phase 3
• SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With ObesityActive, not recruitingNCT04775082Phase 3
• The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone FractureStatus unknownNCT04702516Phase 1/2
• Effects of Glucagon-Like Peptide-1 Analogs on SexualityCompletedNCT04687514Phase 2
• Liraglutide Plus Megestrol Acetate in Endometrial Atypical HyperplasiaWithdrawnNCT04683237Phase 2/3
• Targeting Beta-cell Failure in Lean Patients With Type 2 DiabetesCompletedNCT04657939Phase 4
• Liraglutide for Low-responders After Bariatric SurgeryWithdrawnNCT04643301Not applicable
• A Study of LY3457263 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT04641312Phase 1
• Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19Status unknownNCT04615871Phase 2
• The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight PatientsCompletedNCT04605861Phase 3
• Study of the Cardiometabolic Effects of Obesity PharmacotherapyStatus unknownNCT04575194Phase 4
• Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" TrialCompletedNCT04535960Phase 2
• Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis PatientsStatus unknownNCT04529278Phase 2
• Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbiditiesStatus unknownNCT04525300Phase 3
• Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy PeopleCompletedNCT04524832Phase 1
• Brain Activation and Satiety in Children 2Active, not recruitingNCT04520490Phase 3

← Glucagon-Like Peptide-1 Receptor Agonists overview